GlassScriptPhysician profile
Hope A Moczynski
NPI 1407428329
$5,807.04
in general payments reported to CMS, 2019-2025
14 companies · $2,847 in 2025
The $2,847 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $181 · 2022: $2,348 · 2023: $215 · 2024: $217 · 2025: $2,847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,904 · Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,903.84 |
| Food and Beverage | $1,374.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,530.63 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $1,881.12 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $417.51 | 2021-2025 | Jardiance |
| Abbott Laboratories | $237.27 | 2023-2025 | Aveir, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Pfizer INC. | $220.79 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $119.93 | 2021-2023 | Andexxa |
| Astellas Pharma US INC | $115.00 | 2022 | |
| Merck Sharp & Dohme LLC | $103.43 | 2023 | Verquvo |
| Inspire Medical Systems, INC. | $62.93 | 2024 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $52.09 | 2022 | |
| Novo Nordisk INC | $24.10 | 2023 | Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.58 | 2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $11.75 | 2022 | |
| Daxor Corporation | $10.91 | 2025 | Bva-100 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hope Moczynski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.